UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

þ		QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended September 30, 2007

o		TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                      to                     

DELPHI FINANCIAL GROUP, INC.

(Exact name of registrant as specified in its charter)

Delaware		(302) 478-5142		13-3427277
(State or other jurisdiction of incorporation or organization)		(Registrant’s telephone number, including area code)		(I.R.S. Employer Identification Number)

1105 North Market Street, Suite 1230, P.O. Box 8985, Wilmington, Delaware		19899
(Address of principal executive offices)		(Zip Code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to filing requirements for the past 90 days:

		Yes þ		No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of “accelerated filer and large accelerated filer” in Rule 12b-2 of the Exchange Act. (check one):

Large accelerated filer þ		Accelerated filer o		Non-accelerated filer o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

		Yes o		No þ

As of October 31, 2007, the Registrant had 43,741,428 shares of Class A Common Stock and 5,706,967 shares of Class B Common Stock outstanding.

 

 

DELPHI FINANCIAL GROUP, INC.
FORM 10-Q
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
AND OTHER INFORMATION

				Page
PART I.		FINANCIAL INFORMATION (UNAUDITED)
		Item 1. Financial Statements
		Consolidated Statements of Income for the Three and Nine Months Ended September 30, 2007 and 2006			3
		Consolidated Balance Sheets at September 30, 2007 and December 31, 2006			4
		Consolidated Statements of Shareholders’ Equity for the Nine Months Ended September 30, 2007 and 2006			5
		Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2007 and 2006			6
		Notes to Consolidated Financial Statements			7
		Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations			13
		Item 3. Quantitative and Qualitative Disclosures About Market Risk			19
		Item 4. Controls and Procedures			19
PART II.		OTHER INFORMATION
		Item 1A. Risk Factors			20
		Item 2. Unregistered Sales of Equity Securities and Use of Proceeds			20
		Item 6. Exhibits			21
		Signatures			21

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

DELPHI FINANCIAL GROUP, INC. AND SUBSIDIARIES

		Three Months Ended								Nine Months Ended
		September 30,								September 30,
		2007				2006				2007				2006
Revenue:
Premium and fee income		$	325,944			$	295,190			$	972,528			$	838,419
Net investment income			62,768				66,159				203,178				185,974
Net realized investment losses			(1,480	)			(335	)			(925	)			(1,880	)
Loss on redemption of junior subordinated deferrable interest debentures underlying company-obligated mandatorily redeemable capital securities issued by unconsolidated subsidiaries			—				—				(2,192	)			—
			387,232				361,014				1,172,589				1,022,513
Benefits and expenses:
Benefits, claims and interest credited to policyholders			234,525				217,322				708,220				612,961
Commissions			20,044				18,844				60,638				53,106
Amortization of cost of business acquired			17,426				20,478				58,377				57,715
Other operating expenses			50,162				45,992				149,982				129,133
			322,157				302,636				977,217				852,915
Income from continuing operations before interest and income tax expense			65,075				58,378				195,372				169,598
Interest expense:
Corporate debt			3,328				5,250				12,973				15,029
Junior subordinated debentures			3,246				—				4,652				—
Junior subordinated deferrable interest debentures underlying company-obligated redeemable capital securities issued by unconsolidated subsidiaries			488				1,319				2,251				3,887
			7,062				6,569				19,876				18,916
Income from continuing operations before income tax expense			58,013				51,809				175,496				150,682
Income tax expense			17,284				15,641				52,659				45,858
Income from continuing operations			40,729				36,168				122,837				104,824
Income (loss) from discontinued operations, net of income tax expense (benefit)			—				1				—				(2,932	)
Net income		$	40,729			$	36,169			$	122,837			$	101,892
Basic results per share of common stock:
Income from continuing operations		$	0.80			$	0.73			$	2.44			$	2.12
Net income			0.80				0.73				2.44				2.06
Diluted results per share of common stock:
Income from continuing operations		$	0.79			$	0.71			$	2.38			$	2.06
Net income			0.79				0.71				2.38				2.00
Dividends paid per share of common stock		$	0.09			$	0.08			$	0.26			$	0.23

See notes to consolidated financial statements.

DELPHI FINANCIAL GROUP, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(Dollars in Thousands, Except Per Share Data)

		September 30,				December 31,
		2007				2006
Assets:
Investments:
Fixed maturity securities, available for sale		$	3,624,642			$	3,377,578
Short-term investments			261,434				400,239
Other investments			809,381				705,563
			4,695,457				4,483,380
Cash			45,684				48,204
Cost of business acquired			179,777				267,920
Reinsurance receivables			412,626				410,593
Goodwill			93,929				93,929
Other assets			276,675				251,975
Assets held in separate account			122,833				114,474
Total assets		$	5,826,981			$	5,670,475
Liabilities and Shareholders’ Equity:
Future policy benefits:
Life		$	288,824			$	279,919
Disability and accident			671,945				610,618
Unpaid claims and claim expenses:
Life			67,538				58,752
Disability and accident			334,470				300,693
Casualty			941,412				857,662
Policyholder account balances			1,091,011				1,119,218
Corporate debt			147,750				263,750
Junior subordinated debentures			175,000				—
Junior subordinated deferrable interest debentures underlying company-obligated mandatorily redeemable capital securities issued by unconsolidated subsidiaries			20,619				59,762
Other liabilities and policyholder funds			789,414				830,819
Liabilities related to separate account			122,833				114,474
Total liabilities			4,650,816				4,495,667
Shareholders’ equity:
Preferred Stock, $.01 par; 50,000,000 shares authorized			—				—
Class A Common Stock, $.01 par; 150,000,000 shares authorized; 48,652,044 and 48,010,697 shares issued and outstanding, respectively			487				480
Class B Common Stock, $.01 par; 20,000,000 shares authorized; 5,934,183 and 5,671,744 shares issued and outstanding, respectively			59				57
Additional paid-in capital			503,098				474,722
Accumulated other comprehensive (loss) income			(24,396	)			19,133
Retained earnings			790,817				763,386
Treasury stock, at cost; 4,611,216 and 4,565,716 shares of Class A Common Stock, respectively, and 227,216 and 0 shares of Class B Common Stock, respectively			(93,900	)			(82,970	)
Total shareholders’ equity			1,176,165				1,174,808
Total liabilities and shareholders’ equity		$	5,826,981			$	5,670,475

See notes to consolidated financial statements.

DELPHI FINANCIAL GROUP, INC. AND SUBSIDIARIES

														Accumulated
		Class A				Class B				Additional				Other
		Common				Common				Paid-in				Comprehensive				Retained				Treasury
		Stock				Stock				Capital				Income (Loss)				Earnings				Stock				Total
Balance, January 1, 2006		$	313			$	39			$	442,531			$	20,264			$	636,285			$	(66,393	)		$	1,033,039
Net income			—				—				—				—				101,892				—				101,892
Other comprehensive (loss) income:
Decrease in net unrealized appreciation on investments			—				—				—				(3,852	)			—				—				(3,852	)
Decrease in net loss on cash flow hedge			—				—				—				589				—				—				589
Comprehensive income																											98,629
Issuance of stock, exercise of stock options and share conversions			7				(1	)			21,912				—				—				—				21,918
Stock-based compensation			—				—				6,533				—				—				—				6,533
Acquisition of treasury stock			—				—				—				—				—				(16,577	)			(16,577	)
Cash dividends			—				—				—				—				(11,038	)			—				(11,038	)
Three-for-two stock split			159				19				(179	)			—				—				—				(1	)
Balance, September 30, 2006		$	479			$	57			$	470,797			$	17,001			$	727,139			$	(82,970	)		$	1,132,503
Balance, January 1, 2007		$	480			$	57			$	474,722			$	19,133			$	763,386			$	(82,970	)		$	1,174,808
Cumulative effect adjustment			—				—				—				—				(82,553	)			—				(82,553	)
Adjusted balance, January 1, 2007			480				57				474,722				19,133				680,833				(82,970	)			1,092,255
Net income			—				—				—				—				122,837				—				122,837
Other comprehensive (loss) income:
Decrease in net unrealized appreciation on investments			—				—				—				(44,921	)			—				—				(44,921	)
Decrease in net loss on
cash flow hedge			—				—				—				589				—				—				589
Change in net periodic pension cost			—				—				—				803				—				—				803
Comprehensive income																											79,308
Issuance of stock, exercise of stock options and share conversions			7				2				23,247				—				—				—				23,256
Stock-based compensation			—				—				5,129				—				—				—				5,129
Acquisition of treasury stock			—				—				—				—				—				(10,930	)			(10,930	)
Cash dividends			—				—				—				—				(12,853	)			—				(12,853	)
Balance, September 30, 2007		$	487			$	59			$	503,098			$	(24,396	)		$	790,817			$	(93,900	)		$	1,176,165

See notes to consolidated financial statements.

DELPHI FINANCIAL GROUP, INC. AND SUBSIDIARIES

		Nine Months Ended
		September 30,
		2007				2006
Operating activities:
Net income		$	122,837			$	101,892
Adjustments to reconcile net income to net cash provided by operating activities:
Change in policy liabilities and policyholder accounts			219,478				197,987
Net change in reinsurance receivables and payables			(7,428	)			3,523
Amortization, principally the cost of business acquired and investments			53,353				50,397
Deferred costs of business acquired			(84,042	)			(77,473	)
Net realized losses on investments			925				1,880
Net change in federal income tax liability			16,440				12,193
Other			(41,451	)			(38,463	)
Net cash provided by operating activities			280,112				251,936
Investing activities:
Purchases of investments and loans made			(861,814	)			(898,282	)
Sales of investments and receipts from repayment of loans			328,176				597,301
Maturities of investments			120,486				168,327
Net change in short-term investments			138,805				(202,886	)
Change in deposit in separate account			8,536				(2,234	)
Net cash used by investing activities			(265,811	)			(337,774	)
Financing activities:
Deposits to policyholder accounts			90,388				178,231
Withdrawals from policyholder accounts			(123,802	)			(98,778	)
Borrowings under revolving credit facility			42,000				31,000
Principal payments under revolving credit facility			(158,000	)			(2,000	)
Proceeds from the issuance of 2007 Junior Debentures			172,309				—
Redemption of Junior Debentures			(37,728	)			—
Other financing activities			(1,988	)			(5,612	)
Net cash (used) provided by financing activities			(16,821	)			102,841
(Decrease) increase in cash			(2,520	)			17,003
Cash at beginning of period			48,204				28,493
Cash at end of period		$	45,684			$	45,496

See notes to consolidated financial statements.

DELPHI FINANCIAL GROUP, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

Note A — Significant Accounting Policies

The financial statements of Delphi Financial Group, Inc. (the “Company,” which term includes the Company and its consolidated subsidiaries unless the context indicates otherwise) included herein were prepared in conformity with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. The information furnished includes all adjustments and accruals of a normal recurring nature which, in the opinion of management, are necessary for a fair presentation of results for the interim periods. Certain reclassifications have been made in the September 30, 2006 consolidated financial statements to conform to the September 30, 2007 presentation. Operating results for the three and nine months ended September 30, 2007 are not necessarily indicative of the results that may be expected for the year ended December 31, 2007. For further information refer to the consolidated financial statements and footnotes thereto included in the Company’s annual report on Form 10-K for the year ended December 31, 2006 (the “2006 Form 10-K”). Capitalized terms used herein without definition have the meanings ascribed to them in the 2006 Form 10-K.

Accounting Changes

Cost of Business Acquired. As of January 1, 2007, the Company adopted the American Institute of Certified Public Accountants (“AICPA”) Statement of Position (“SOP”) 05-1, “Accounting by Insurance Enterprises for Deferred Acquisition Costs in Connection With Modifications or Exchanges of Insurance Contracts.” SOP 05-1 provides accounting guidance for deferred policy acquisition costs associated with internal replacements of insurance and investment contracts not addressed by previous guidance, including group insurance contracts. This statement defines an internal replacement as a modification in product benefits, features, rights, or coverages that occurs by the exchange of a contract for a new contract, or by amendment, endorsement or rider to a contract, or by the election of a feature or coverage within a contract. Internal replacement transactions that are determined to result in substantial changes to the replaced contracts are accounted for as extinguishments of the replaced contracts, and any unamortized deferred acquisition costs and other balances related to the replaced contracts are immediately recognized as expense in the income statement. Internal replacement transactions that are determined to result in replacement contracts that are substantially unchanged from the replaced contract are accounted for as continuations of the replaced contracts. Unamortized deferred acquisition costs and unearned revenue liabilities related to the replaced contract continue to be deferred and amortized in connection with the replacement contracts. Any costs associated with the issuance of the replacement contracts are characterized as maintenance costs and expensed as incurred. The Company made an after-tax reduction to its retained earnings at January 1, 2007, the date of adoption of SOP 05-1, in the amount of $82.6 million, which represents the net reduction in the deferred policy acquisition cost from internal replacements included in cost of business acquired on the consolidated balance sheet.

Hybrid Financial Instruments. As of January 1, 2007, the Company adopted Financial Accounting Standards Board (“FASB”) Statement of Financial Accounting Standards (“SFAS”) No. 155, “Accounting for Certain Hybrid Financial Instruments — an amendment of SFAS No. 133 and SFAS No. 140,” which is effective for all financial instruments acquired or issued after January 1, 2007. This standard (a) permits fair value remeasurement of an entire hybrid financial instrument that contains an embedded derivative that otherwise would require bifurcation; (b) clarifies which interest-only and principal-only securities are not subject to the requirements of SFAS No. 133; (c) establishes a requirement to evaluate interests in securitized financial assets to identify interests that are freestanding derivatives or that are hybrid financial instruments that contain an embedded derivative requiring bifurcation; (d) clarifies that concentrations of credit risk in the form of subordination are not embedded derivatives; and (e) amends SFAS No. 140 to eliminate restrictions on a qualifying special purpose entity’s ability to hold a passive derivative financial instrument that pertains to beneficial interests that are or contain a derivative financial instrument. The adoption of SFAS No. 155 did not have a material effect on the Company’s financial condition or results of operations.

Income Taxes. As of January 1, 2007, the Company adopted FASB Interpretation (“FIN”) No. 48, “Accounting for Uncertainty in Income Taxes — an interpretation of SFAS No. 109.” FIN No. 48 clarifies the accounting for uncertainty in tax positions taken or expected to be taken by a company in a tax return by prescribing a financial statement recognition threshold and measurement attribute for such positions. The Interpretation applies to positions for all open tax years. The Company’s tax years through 2002 are closed to further assessment by the Internal Revenue Service. FIN No. 48 requires that companies recognize the impact of the tax position if that position is more likely than not of being sustained on audit, based on the technical merits of the position. This interpretation also provides guidance on classification, interest, penalties, accounting in interim periods and disclosure. The adoption of FIN No. 48 did not have a material effect on the Company’s financial condition or results of operations.

DELPHI FINANCIAL GROUP, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
(Unaudited)

Note A — Significant Accounting Policies — (Continued)

Recently Issued Accounting Standards

In September 2006, the FASB issued SFAS No. 157, “Fair Value Measurements”, which addresses the manner in which fair value should be measured under GAAP. SFAS No. 157 provides a common definition of fair value and establishes a framework that fair value measures should follow under GAAP, but this statement does not supersede existing guidance on when fair value measures should be used. This standard will also require companies to disclose the extent to which they measure assets and liabilities at fair value, the methods and assumptions they use to measure fair value, and the effect of fair value measures on their earnings. This statement is effective for financial statements issued for fiscal years beginning after November 15, 2007. The Company has not yet determined the impact, if any, that the adoption of SFAS No. 157 will have on its consolidated financial position or results of operations.

In February 2007, the FASB issued SFAS No. 159, “The Fair Value Option for Financial Assets and Financial Liabilities”. SFAS No. 159 allows entities to choose, at specified election dates, to measure many financial assets and financial liabilities (as well as certain nonfinancial instruments that are similar to financial instruments) at fair value (the “fair value option”). The election is made on an instrument-by-instrument basis and is irrevocable. SFAS No. 159 provides entities with a one-time opportunity, upon initial adoption of this statement, to elect the fair value option for existing eligible items. Upon such election, any differences between the carrying amount of the selected item and its fair value as of the effective date would be included in the cumulative-effect adjustment to beginning retained earnings and all subsequent changes in fair value for the instrument elected would be reported in earnings. By electing the fair value option, an entity can achieve consistent accounting for related assets and liabilities without having to apply complex hedge accounting provisions. This statement is effective as of the beginning of an entity’s first fiscal year that begins after November 15, 2007. Earlier adoption of the statement is permitted upon satisfaction of certain conditions. The Company has not yet made a decision on whether to use the fair value option with respect to any of its eligible financial or nonfinancial instruments.

In June 2007, the AICPA issued SOP 07-1, “Clarification of the Scope of the Audit and Accounting Guide Investment Companies and Accounting by Parent Companies and Equity Method Investors for Investments in Investment Companies.” Upon adoption of this SOP, companies must also adopt the provisions of FASB Staff Position No. FIN 46(R)-7, “Application of FASB Interpretation No. 46(R) to Investment Companies” (“FSP FIN 46(R)-7”), which permanently exempts investment companies from applying the provisions of Interpretation 46(R) to investments carried at fair value. SOP 07-1 provides guidance for determining whether an entity is within the scope of the AICPA Audit and Accounting Guide Investment Companies (the “Guide”). Companies subject to the Guide are required to record all of their investments at fair value, with changes in value being reflected in earnings. For an entity that is subject to the Guide, SOP 07-1 also addresses whether a parent company of, or equity method investor in, such entity should utilize the specialized accounting standards of the Guide in its consolidated financial statements. The provisions of SOP 07-1 and FSP FIN 46(R)-7 are effective for fiscal years beginning on or after December 15, 2007, with earlier adoption permitted. In October 2007, the FASB voted and agreed to issue an exposure draft that would indefinitely delay the effective date of SOP 07-1. The Company is in the process of determining the effect that SOP 07-1 and FSP FIN 46(R)-7 may have, if any, on its consolidated financial position or results of operations.

Note B — Investments

At September 30, 2007, the Company had fixed maturity securities available for sale with a carrying value and a fair value of $3,624.6 million and an amortized cost of $3,668.8 million. At December 31, 2006, the Company had fixed maturity securities available for sale with a carrying value and a fair value of $3,377.6 million and an amortized cost of $3,340.8 million.

DELPHI FINANCIAL GROUP, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
(Unaudited)

Note C — Redemption of Junior Subordinated Deferrable Interest Debentures underlying the Company-Obligated Mandatorily Redeemable Capital Securities of Delphi Funding L.L.C.

In 1997, Delphi Funding L.L.C. (“Delphi Funding”) issued $100.0 million liquidation amount of 9.31% Capital Securities, Series A (the “Capital Securities”) in a public offering. In connection with the issuance of the Capital Securities and the related purchase by the Company of all of the common limited liability company interests of Delphi Funding, the Company issued to Delphi Funding $103.1 million principal amount of 9.31% junior subordinated deferrable interest debentures, Series A, due 2027 (the “Junior Debentures”). During 2001, the Company repurchased $64.0 million liquidation amount of the Capital Securities in the open market.

On March 27, 2007, Delphi Funding redeemed the remaining $36.0 million liquidation amount of Capital Securities concurrently with the redemption by the Company of the underlying Junior Debentures held by Delphi Funding. The redemption price was $1,046.55 per Capital Security plus accrued dividends. As a result, the $103.1 million principal amount of the Junior Debentures ceased to be outstanding and dividends on the Junior Debentures ceased to accrue. The Company recognized a pre-tax loss of $2.2 million on the redemption during the first quarter of 2007. The Company utilized borrowings under its Amended Credit Agreement and cash on hand to fund such redemption.

Note D — Junior Subordinated Debentures

On May 23, 2007, the Company completed the issuance of $175.0 million aggregate principal amount of fixed-to-floating rate junior subordinated debentures (the “2007 Junior Debentures”), pursuant to an effective registration statement. The 2007 Junior Debentures bear interest at a fixed rate of 7.376%, payable quarterly in arrears until May 15, 2017, at which time the interest rate changes to a variable rate equal to the London interbank offered interest rate for three-month U.S. dollar deposits plus 3.19%, payable quarterly in arrears. The 2007 Junior Debentures will become due on May 15, 2037, the scheduled maturity date, but only to the extent that the Company has received sufficient net proceeds from the sale of certain qualifying capital securities, as defined. The Company will be required to use its commercially reasonable efforts, subject to certain market disruption events, to sell a sufficient amount of qualifying securities to permit repayment of the 2007 Junior Debentures in full on the scheduled maturity date or as soon thereafter as possible. Any remaining outstanding principal amount will be due on May 1, 2067, the final maturity date. Subject to certain exceptions and limitations, the Company may elect, on one or more occasions, to defer payment of interest on the 2007 Junior Debentures. The Company will not be required to settle deferred interest until it has deferred interest for five consecutive years or, if earlier, has made a payment of current interest during a deferral period. The Company may defer interest for a period of up to ten consecutive years without giving rise to an event of default. During any such deferral period, additional interest would accrue on the deferred interest at the same rate as on the 2007 Junior Debentures and the Company would not be permitted to, among other things, pay dividends on or make certain repurchases of its common stock. The Company may elect to redeem any or all of the 2007 Junior Debentures at any time. In the case of a redemption before May 15, 2017, the redemption price will be equal to the greater of 100% of the principal amount of the 2007 Junior Debentures being redeemed and the applicable make-whole amount, in each case plus any accrued and unpaid interest. In the case of a redemption on or after May 15, 2017, the redemption price will be equal to 100% of the principal amount of the debentures being redeemed plus any accrued and unpaid interest. The proceeds from this issuance were used to repay all borrowings then outstanding under the Amended Credit Agreement and for other general corporate purposes.

On May 27, 2007, in connection with the issuance of the 2007 Junior Debentures, the Company entered into a replacement capital covenant (the “Replacement Capital Covenant”) for the benefit of holders of one or more designated series of the Company’s indebtedness (which will initially be the 8.00% Senior Notes due 2033). Under the terms of the Replacement Capital Covenant, neither the Company or any of its subsidiaries will repay, redeem, defease or purchase the 2007 Junior Debentures before May 15, 2033, unless, subject to certain limitations, the Company has received qualifying proceeds from the sale of replacement capital securities, as defined.

DELPHI FINANCIAL GROUP, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
(Unaudited)

Note E — Segment Information

		Three Months Ended								Nine Months Ended
		September 30,								September 30,
		2007				2006				2007				2006
						(dollars in thousands)
Revenues:
Group employee benefit products		$	358,426			$	325,743			$	1,070,159			$	923,902
Asset accumulation products			19,944				26,315				74,523				73,718
Other(1)			10,342				9,291				31,024				26,773
			388,712				361,349				1,175,706				1,024,393
Net realized investment losses			(1,480	)			(335	)			(925	)			(1,880	)
Loss on redemption of junior subordinated deferrable interest debentures underlying the Company-obligated mandatorily redeemable capital securities issued by unconsolidated subsidiaries			—				—				(2,192	)			—
		$	387,232			$	361,014			$	1,172,589			$	1,022,513
Operating income (loss):
Group employee benefit products		$	67,234			$	57,820			$	195,308			$	164,907
Asset accumulation products			6,946				8,134				24,112				21,485
Other(1)			(7,625	)			(7,241	)			(20,931	)			(14,914	)
			66,555				58,713				198,489				171,478
Net realized investment losses			(1,480	)			(335	)			(925	)			(1,880	)
Loss on redemption of junior subordinated deferrable interest debentures underlying the Company-obligated mandatorily redeemable capital securities issued by unconsolidated subsidiaries			—				—				(2,192	)			—
		$	65,075			$	58,378			$	195,372			$	169,598

Note F — Comprehensive Income

Total comprehensive income is comprised of net income and other comprehensive income (loss), which includes the change in unrealized gains and losses on securities available for sale, change in net periodic pension cost and the change in the loss on the cash flow hedge described in the 2006 Form 10-K. Total comprehensive income was $79.3 million and $98.6 million for the first nine months of 2007 and 2006, respectively, and $40.7 million and $87.1 million for the third quarters of 2007 and 2006, respectively.

DELPHI FINANCIAL GROUP, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
(Unaudited)

Note G — Stock-Based Compensation

Effective January 1, 2006, the Company adopted SFAS No. 123 (Revised) (“123R”), “Share-Based Payment,” using the modified prospective transition method, under which compensation cost is recognized for all new awards granted after the date of adoption and any unvested awards previously granted for which expenses were not being recognized under SFAS No. 123. The Company recognized stock-based compensation expense of $6.9 million and $7.2 million in the first nine months of 2007 and 2006, respectively, of which $2.3 million and $3.5 million was recognized in the third quarter of 2007 and 2006, respectively. The remaining unrecognized compensation expense related to unvested awards at September 30, 2007 was $17.9 million and the weighted average period of time over which this expense will be recognized is 3.3 years.

The fair values of options were estimated at the grant date using the Black-Scholes option pricing model with the following weighted average assumptions for the first nine months of 2007: expected volatility — 19.2%, expected dividends — 0.8%, expected lives of the options — 6.5 years and the risk free rate — 4.6%. The following weighted average assumptions were used for the first nine months of 2006: expected volatility — 24.4%, expected dividends — 0.9%, expected lives of the options — 6.5 years, and the risk free rate — 4.8%.

The expected volatility reflects the Company’s past monthly stock price volatility. The expected lives of options granted in the first nine months of 2007 and 2006 were calculated using the “simplified method” in accordance with Staff Accounting Bulletin 107. The dividend yield is based on the Company’s historical dividend payments. The risk-free rate is derived from public data sources at the time of each option grant. Compensation cost is recognized over the requisite service period of the option using the straight-line method.

Option activity with respect to the Company’s plans, excluding the performance-contingent incentive options referenced further below, was as follows:

										Weighted
						Weighted				Average				Aggregate
		Number				Average				Remaining				Intrinsic
		of				Exercise				Contractual				Value
Options		Options				Price				Term				($000)
Outstanding at January 1, 2007			3,552,668			$	20.93
Granted			790,571				40.68
Exercised			(889,170	)			16.86
Forfeited			(39,101	)			32.63
Outstanding at September 30, 2007			3,414,968				26.43				5.6			$	48,054
Exercisable at September 30, 2007			1,928,476			$	18.96				3.1			$	41,385

The weighted average grant date fair value of options granted during the first nine months of 2007 and 2006 was $11.45 and $8.07, respectively, and during the third quarter of 2007 was $10.94. The Company did not grant any options during the third quarter of 2006. The cash proceeds from stock options exercised were $8.2 million and $10.1 million for the first nine months of 2007 and 2006, respectively, and $1.1 million and $4.7 million for the third quarter of 2007 and 2006, respectively. During the third quarter of 2007, the Company received previously issued shares of Class B Common Stock having an aggregate value of $9.1 million in payment of the exercise price and tax withholdings in connection with a stock option exercise. The value of such shares is included in treasury stock. The total intrinsic value of options exercised during the first nine months of 2007 and 2006 was $22.2 million and $17.2 million, respectively.

At September 30, 2007, 3,515,750 performance contingent incentive options were outstanding with a weighted average exercise price of $24.18, a weighted average contractual term of 6.3 years and an intrinsic value of $57.1 million. 703,250 options with a weighted average exercise price of $27.87, a weighted average contractual term of 6.6 years and an intrinsic value of $8.8 million were exercisable at September 30, 2007.

DELPHI FINANCIAL GROUP, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
(Unaudited)

Note H — Computation of Results per Share

The following table sets forth the calculation of basic and diluted results per share:

		Three Months Ended								Nine Months Ended
		September 30,								September 30,
		2007				2006				2007				2006
		(dollars in thousands, except per share data)
Numerator:
Income from continuing operations		$	40,729			$	36,168			$	122,837			$	104,824
Income (loss) from discontinued operations, net of income tax expense (benefit)			—				1				—				(2,932	)
Net income		$	40,729			$	36,169			$	122,837			$	101,892
Denominator:
Weighted average common shares outstanding			50,596				49,652				50,405				49,531
Effect of dilutive securities			1,126				1,274				1,236				1,293
Weighted average common shares outstanding, assuming dilution			51,722				50,926				51,641				50,824
Basic results per share of common stock:
Income from continuing operations		$	0.80			$	0.73			$	2.44			$	2.12
Loss from discontinued operations, net of income tax benefit			—				—				—				(0.06	)
Net income		$	0.80			$	0.73			$	2.44			$	2.06
Diluted results per share of common stock:
Income from continuing operations		$	0.79			$	0.71			$	2.38			$	2.06
Loss from discontinued operations, net of income tax benefit			—				—				—				(0.06	)
Net income		$	0.79			$	0.71			$	2.38			$	2.00

DELPHI FINANCIAL GROUP, INC.

Introduction

The Company, through its subsidiaries, underwrites a diverse portfolio of group employee benefit products, primarily disability, group life, and excess workers’ compensation insurance. Revenues from this group of products are primarily comprised of earned premiums and investment income. The profitability of group employee benefit products is affected by, among other things, differences between actual and projected claims experience, the retention of existing customers, product mix and the Company’s ability to attract new customers, change premium rates and contract terms for existing customers and control administrative expenses. The Company cedes its exposure to a portion of its group employee benefit risks through indemnity reinsurance arrangements with other insurance and reinsurance companies. Accordingly, the profitability of the Company’s group employee benefit products is affected by the amount, cost and terms of reinsurance it obtains. The profitability of those group employee benefit products for which reserves are discounted is also affected by the difference between the yield achieved on invested assets and the discount rate used to calculate the related reserves. The Company is benefiting from the favorable market conditions which had in recent years prevailed for its excess workers’ compensation products. For its other group employee benefit products, the Company is continuing to increase the size of its sales force in order to enhance its focus on the small case niche (insured groups of 10 to 500 individuals), including employers which are first-time providers of these employee benefits, which the Company believes to offer opportunities for superior profitability. The Company is also emphasizing its suite of voluntary group insurance products, which includes, among others, its group limited benefit health insurance product. The Company markets its other group employee benefit products on an unbundled basis and as part of an integrated employee benefit program that combines employee benefit insurance coverages and absence management services. The integrated employee benefit program, which the Company believes helps to differentiate itself from competitors by offering clients improved productivity from reduced employee absence, has enhanced the Company’s ability to market its other group employee benefit products to large employers.

The Company also operates an asset accumulation business that focuses primarily on offering fixed annuities to individuals. In addition, during the first quarter of 2006, the Company issued $100 million in aggregate principal amount of fixed and floating rate funding agreements with maturities of three to five years in connection with the issuance by an unconsolidated special purpose vehicle of funding agreement-backed notes in a corresponding principal amount. The Company believes that the funding agreement program enhances the Company’s asset accumulation business by providing an alternative source of distribution for this business. The Company’s liability for the funding agreements is recorded in policyholder account balances. Deposits from the Company’s asset accumulation business are recorded as liabilities rather than as premiums. Revenues from the Company’s asset accumulation business are primarily comprised of investment income earned on the funds under management. The profitability of asset accumulation products is primarily dependent on the spread achieved between the return on investments and the interest credited to holders of these products. The Company sets the crediting rates offered on its asset accumulation products in an effort to achieve its targeted interest rate spreads on these products, and is willing to accept lower levels of sales on these products when market conditions make these targeted spreads more difficult to achieve.

The following discussion and analysis of the results of operations and financial condition of the Company should be read in conjunction with the Consolidated Financial Statements and related notes included in this document, as well as the Company’s annual report on Form 10-K for the year ended December 31, 2006 (the “2006 Form 10-K”). Capitalized terms used herein without definition have the meanings ascribed to them in the 2006 Form 10-K. The preparation of financial statements in conformity with GAAP requires management, in some instances, to make judgments about the application of these principles. The amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period could differ materially from the amounts reported if different conditions existed or different judgments were utilized. A discussion of how management applies certain critical accounting policies and makes certain estimates is contained in the 2006 Form 10-K in the section entitled “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Critical Accounting Policies and Estimates” and should be read in conjunction with the following discussion and analysis of results of operations and financial condition of the Company. In addition, a discussion of uncertainties and contingencies which can affect actual results and could cause future results to differ materially from those expressed in certain forward-looking statements contained in this Management’s Discussion and Analysis of Financial Condition and Results of Operations can be found below under the caption “Forward-Looking Statements And Cautionary Statements Regarding Certain Factors That May Affect Future Results,” in Part I, Item 1A of the 2006 Form 10-K, “Risk Factors,” and in Part II, Item 1A of this Quarterly Report, “Risk Factors”.

Results of Operations

Nine Months Ended September 30, 2007 Compared to
Nine Months Ended September 30, 2006

Summary of Results. Net income was $122.8 million, or $2.38 per diluted share, in the first nine months of 2007 as compared to $101.9 million, or $2.00 per diluted share, in the first nine months of 2006. Net income in the first nine months of 2007 and 2006 included realized investment losses (net of the related income tax benefit) of $0.6 million, or $0.01 per diluted share, and $1.2 million, or $0.03 per diluted share, respectively. Net income in the first nine months of 2007 benefited from growth in income from the Company’s core group employee benefit products, increased investment spreads on the Company’s asset accumulation products and an increase in net investment income, and was adversely impacted by a loss on the redemption of junior subordinated deferrable interest debentures. Core group employee benefit products include disability, group life, excess workers’ compensation, travel accident and dental insurance. Premiums from these core group employee benefit products increased 15% in the first nine months of 2007. The combined ratio (loss ratio plus expense ratio) for group employee benefit products decreased to 92.5% in the first nine months of 2007 from 93.1% in the first nine months of 2006. The 9% increase in net investment income in the first nine months of 2007 as compared to the first nine months of 2006 reflects a 13% increase in average invested assets. During the first nine months of 2007, the Company recognized a loss (net of the related income tax benefit) of $1.4 million, or $0.03 per diluted share, from the redemption of the 9.31% junior subordinated deferrable interest debentures underlying the 9.31% Capital Securities, Series A of Delphi Funding L.L.C.

Premium and Fee Income. Premium and fee income in the first nine months of 2007 was $972.5 million as compared to $838.4 million in the first nine months of 2006, an increase of 16%. Premiums from core group employee benefit products increased 15% to $916.3 million in the first nine months of 2007 from $798.2 million in the first nine months of 2006. This increase reflects normal growth in employment and salary levels for the Company’s existing customer base, price increases, and new business production. Premiums from excess workers’ compensation insurance for self-insured employers increased 9% to $209.2 million in the first nine months of 2007 from $191.3 million in the first nine months of 2006. This increase was primarily due to the continuing substantial level of demand for this product. Excess workers’ compensation premiums in the first nine months of 2007 included $3.5 million of 2006 policy year premiums from Canadian policies assumed by SNCC in the first quarter of 2007 under the renewal rights agreement into which SNCC entered in 2005 (the “Renewal Rights Agreement”), pursuant to Canadian regulatory approval received in the first quarter. Excess workers’ compensation new business production, which represents the amount of new annualized premium sold, was $27.8 million in the first nine months of 2007, including $3.4 million from the Renewal Rights Agreement, compared to $53.4 million in the first nine months of 2006, including $25.8 million from such agreement. The retention of existing customers in the first nine months of 2007 remained strong.

Premiums from the Company’s other core group employee benefit products increased 17% to $707.0 million in the first nine months of 2007 from $606.9 million in the first nine months of 2006, primarily reflecting a 16% increase in premiums from the Company’s group disability products, new business production, improved retention of existing customers and a decrease in premiums ceded by the Company to reinsurers for these products. During the first nine months of 2007, premiums from the Company’s group disability products increased to $391.7 million from $338.1 million in the first nine months of 2006, primarily reflecting new business production. Premiums from the Company’s turnkey disability business were $38.0 million and $37.7 million during the first nine months of 2007 and 2006, respectively. New business production for the Company’s other core group employee benefit products increased 35% to $179.3 million in the first nine months of 2007 as compared to $133.0 million in the first nine months of 2006, reflecting growth in the Company’s integrated employee benefits program and its suite of voluntary group insurance products, which includes, among others, its group limited benefit health insurance product. New business production includes only directly written business, and does not include premiums from the Company’s turnkey disability business. The level of production achieved from these products reflects the Company’s focus on the small case niche (insured groups of 10 to 500 individuals). The Company continued to implement price increases for certain existing disability and group life customers.

Non-core group employee benefit products include loss portfolio transfers, primary workers’ compensation, bail bond insurance, workers’ compensation reinsurance and reinsurance facilities. Premiums from non-core group employee benefit products were $29.6 million in the first nine months of 2007 as compared to $17.0 million in the first nine months of 2006, primarily due to a higher level of premium from loss portfolio transfers, which are episodic in nature.

Deposits from the Company’s asset accumulation products were $83.8 million in the first nine months of 2007 as compared to $171.1 million in the first nine months of 2006. This decrease in deposits was primarily due to the issuance of $100.0 million of fixed and floating rate funding agreements during the first quarter of 2006 under a new program of the Company under which funding agreement-backed notes are issued to institutional investors by an unconsolidated special purpose vehicle which uses the proceeds to purchase from the Company funding agreements having terms substantially similar to those of the notes. Deposits

from the Company’s asset accumulation products, consisting of new annuity sales and issuances of funding agreements, are recorded as liabilities rather than as premiums.

Net Investment Income. Net investment income in the first nine months of 2007 was $203.2 million as compared to $186.0 million in the first nine months of 2006, an increase of 9%. The level of net investment income in the 2007 period reflects a 13% increase in average invested assets in the first nine months of 2007 from the first nine months of 2006. The tax equivalent weighted average annualized yield on invested assets was 6.3% and 6.4% for the first nine months of 2007 and 2006, respectively.

Net Realized Investment Losses. Net realized investment losses were $0.9 million in the first nine months of 2007 as compared to $1.9 million in the first nine months of 2006. The Company’s investment strategy results in periodic sales of securities and, therefore, the recognition of realized investment gains and losses. During the first nine months of 2007 and 2006, the Company recognized net gains of $1.6 million and $1.4 million, respectively, on the sales of securities. The Company monitors its investments on an ongoing basis. When the market value of a security declines below its cost, and management judges the decline to be other than temporary, the security is written down to fair value, and the decline is reported as a realized investment loss. In the first nine months of 2007 and 2006, the Company recognized $2.5 million and $3.3 million, respectively, of losses due to the other than temporary declines in the market values of certain fixed maturity securities.

The Company may recognize additional losses of this type in the future. The Company anticipates that if certain other existing declines in security values are determined to be other than temporary, it may recognize additional investment losses in the range of $5 million to $10 million, on an after-tax basis, with respect to the relevant securities. However, the extent of any such losses will depend on future market developments and changes in security values, and such losses may be outside this range. The Company continuously monitors the affected securities pursuant to its procedures for evaluation for other than temporary impairment in valuation, which are described in the section entitled “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Critical Accounting Policies and Estimates — Investments” in the 2006 Form 10-K. It is not possible to predict the extent of any future changes in value, positive or negative, or the results of the future application of these procedures, with respect to these securities. There can be no assurance that the Company will realize investment gains in the future in an amount sufficient to offset any such losses.

Loss on Redemption of Junior Subordinated Deferrable Interest Debentures. During the first nine months of 2007, the Company recognized a pre-tax loss of $2.2 million from the redemption of the 9.31% junior subordinated deferrable interest debentures (“Junior Debentures”) underlying the 9.31% Capital Securities, Series A (“Capital Securities”) of Delphi Funding L.L.C. On March 27, 2007, Delphi Funding L.L.C. redeemed the remaining $36.0 million liquidation amount of Capital Securities concurrently with the redemption by the Company of the underlying Junior Debentures held by Delphi Funding L.L.C. The redemption price was $1,046.55 per Capital Security plus accrued dividends. As a result, the $103.1 million principal amount of the Junior Debentures ceased to be outstanding and dividends on the Capital Securities ceased to accrue.

Benefits and Expenses. Policyholder benefits and expenses were $977.2 million in the first nine months of 2007 as compared to $852.9 million in the first nine months of 2006, an increase of 15%. This increase primarily reflects the increase in premiums from the Company’s group employee benefit products discussed above, and does not reflect significant additions to reserves for prior years’ claims and claim expenses. However, there can be no assurance that future periods will not include additions to reserves of this type, which will depend on the Company’s future loss development. If the Company were to experience significant adverse loss development in the future, the Company’s results of operations could be materially adversely affected. The combined ratio (loss ratio plus expense ratio) for group employee benefit products decreased to 92.5% in the first nine months of 2007 from 93.1% in the first nine months of 2006. Amortization of cost of business acquired was decelerated by $1.6 million during the first nine months of 2007, primarily due to the decrease in the Company’s tax equivalent weighted average annualized yield on invested assets during the third quarter of 2007. The weighted average annualized crediting rate on the Company’s asset accumulation products, which reflects the effects of the first year bonus crediting rate on certain newly issued products, was 4.3% and 4.5% for the first nine months of 2007 and 2006, respectively.

Income Tax Expense. Income tax expense was $52.7 million in the first nine months of 2007 as compared to $45.9 million in the first nine months of 2006. The Company’s effective tax rate was 30.0% in the first nine months of 2007 and 30.4% in the first nine months of 2006.

Three Months Ended September 30, 2007 Compared to
Three Months Ended September 30, 2006

Summary of Results. Net income was $40.7 million, or $0.79 per diluted share, for the third quarter of 2007 as compared to $36.2 million, or $0.71 per diluted share, for the third quarter of 2006. Net income in the third quarter of 2007 and 2006 included realized investment losses (net of the related income tax benefit) of $1.0 million, or $0.02 per diluted share, and $0.2 million, or $0 per diluted share, respectively. Net income in the third quarter of 2007 benefited from the growth in income from the Company’s core group employee benefit products and was adversely impacted by a decrease in net investment income. Premiums from the Company’s core group employee benefit products increased 10% in the third quarter of 2007. The combined ratio (loss ratio plus expense ratio) for group employee benefit products decreased to 91.9% in the third quarter of 2007 from 93.3% in the third quarter of 2006. The decreased level of net investment income reflects a lower tax equivalent weighted average annualized yield on invested assets of 5.7% compared to 6.6% for the third quarter of 2006.

Premium and Fee Income. Premium and fee income for the third quarter of 2007 was $325.9 million as compared to $295.2 million for the third quarter of 2006, an increase of 10%. Premiums from core group employee benefit products increased 10% to $306.6 million in the third quarter of 2007 from $279.8 million in the third quarter of 2006. This increase reflects normal growth in employment and salary levels for the Company’s existing customer base, price increases, and new business production. Premiums from excess workers’ compensation insurance for self-insured employers increased slightly to $68.1 million in the third quarter of 2007 from $67.7 million in the third quarter of 2006. SNCC has substantially maintained its pricing on its third quarter 2007 renewals and SIRs are on average up modestly in third quarter 2007 new and renewal policies. Excess workers’ compensation new business production, which represents the amount of new annualized premium sold, was $8.3 million in the third quarter of 2007 compared to $19.7 million in the third quarter of 2006, which included new business production of $6.3 million from the Renewal Rights Agreement. The retention of existing customers in the third quarter of 2007 remained strong.

Premiums from the Company’s other core group employee benefit products increased 12% to $238.4 million for the third quarter of 2007 from $212.1 million for the third quarter of 2006, primarily reflecting new business production, improved retention of existing customers, a decrease in premiums ceded by the Company to reinsurers for these products, and a 11% increase in premiums from the Company’s group disability products. During the third quarter of 2007, premiums from the Company’s group disability products increased to $132.6 million from $119.2 in the third quarter of 2006, primarily reflecting new business production. Premiums from the Company’s turnkey disability business were $12.5 million during the third quarter of 2007 compared to $16.6 million during the third quarter of 2006. New business production for the Company’s other core group employee benefit products increased 15% to $51.0 million in the third quarter of 2007 as compared to $44.4 million in the third quarter of 2006, reflecting growth in the Company’s integrated employee benefits program and its suite of voluntary group insurance products, which includes its group limited benefit health insurance product. New business production includes only directly written business, and does not include premiums from the Company’s turnkey disability business. The level of production achieved from these products reflects the Company’s focus on the small case niche (insured groups of 10 to 500 individuals). The Company continued to implement price increases for certain existing disability and group life customers.

Deposits from the Company’s asset accumulation products were $32.6 million for the third quarter of 2007 as compared to $26.3 million for the third quarter of 2006. Deposits from the Company’s asset accumulation products, consisting of new annuity sales and issuances of funding agreements, are recorded as liabilities rather than as premiums.

Net Investment Income. Net investment income in the third quarter of 2007 was $62.8 million as compared to $66.2 million in the third quarter of 2006. The level of net investment income in the 2007 period reflects a decrease in the tax equivalent weighted average annualized yield on invested assets to 5.7% for the third quarter of 2007 from 6.6% for the third quarter of 2006, primarily due to adverse performance in the Company’s trading account securities which resulted from the turbulent market environment in the third quarter of 2007. This decrease was partially offset by a 12% increase in average invested assets in such period.

Net Realized Investment Losses. Net realized investment losses were $1.5 million in the third quarter of 2007 as compared to net realized investment losses of $0.3 million in the third quarter of 2006. The Company’s investment strategy results in periodic sales of securities and, therefore, the recognition of realized investment gains and losses. During the third quarters of 2007 and 2006, the Company recognized $(0.9) million and $0.8 million, respectively, of net (losses) gains on sales of securities. The Company monitors its investments on an ongoing basis. When the market value of a security declines below its cost, and management judges the decline to be other than temporary, the security is written down to fair value, and the decline is reported as a realized investment loss. In the third quarters of 2007 and 2006, the Company recognized $0.6 million and $1.1 million, respectively, of losses due to the other than temporary declines in the market values of certain fixed maturity securities.

The Company may recognize additional losses of this type in the future. The Company anticipates that if certain other existing declines in security values are determined to be other than temporary, it may recognize additional investment losses in the range of $5 million to $10 million, on an after-tax basis, with respect to the relevant securities. However, the extent of any such losses will depend on future market developments and changes in security values, and such losses may be outside this range. The Company continuously monitors the affected securities pursuant to its procedures for evaluation for the other than temporary impairment in valuation which are described in the section entitled “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Critical Accounting Policies and Estimates – Investments” in the 2006 Form 10-K. It is not possible to predict the extent of any future changes in value, positive or negative, or the results of the future application of these procedures, with respect to these securities. There can be no assurance that the Company will realize investment gains in the future in an amount sufficient to offset any such losses.

Benefits and Expenses. Policyholder benefits and expenses were $322.2 million in the third quarter of 2007 as compared to $302.6 million in the third quarter of 2006, an increase of 6.5%. This increase primarily reflects the increase in premiums from the Company’s group employee benefit products discussed above, and does not reflect significant additions to reserves for prior years’ claims and claim expenses. However, there can be no assurance that future periods will not include additions to reserves of this type, which will depend on the Company’s future loss development. If the Company were to experience significant adverse loss development in the future, the Company’s results of operations could be materially adversely affected. The combined ratio (loss ratio plus expense ratio) for the Company’s group employee benefits products was 91.9% and 93.3% in the third quarter of 2007 and 2006, respectively. Amortization of cost of business acquired was decelerated by $3.5 million during the third quarter of 2007, primarily due to the decrease in the Company’s tax equivalent weighted average annualized yield on invested assets. The weighted average annualized crediting rate on the Company’s asset accumulation products, which reflects the effect of the first year bonus crediting rate on certain newly issued products, was 4.3% and 4.5% in the third quarter of 2007 and 2006, respectively.

Income Tax Expense. Income tax expense was $17.3 million in the third quarter of 2007 as compared to $15.6 million in the third quarter of 2006. The Company’s effective tax rate was 29.8% in the third quarter of 2007 and 30.2% in the third quarter of 2006.

Liquidity and Capital Resources

General. The Company had approximately $113.7 million of financial resources available at the holding company level at September 30, 2007, which were primarily comprised of investments in the common stock of its investment subsidiaries, investments in limited partnerships and limited liability companies and short-term investments. The assets of the investment subsidiaries are primarily invested in limited partnerships and limited liability companies. Other sources of liquidity at the holding company level include dividends paid from subsidiaries, primarily generated from operating cash flows and investments. The Company’s insurance subsidiaries would be permitted, without prior regulatory approval, to make dividends payments totaling $83.7 million during 2007, of which $3.6 million has been paid during the first nine months of 2007. In general, dividends from the Company’s non-insurance subsidiaries are not subject to regulatory or other restrictions. A shelf registration statement is also in effect under which securities yielding proceeds of up to $106.2 million may be issued by the Company. In addition, the Company is categorized as a well known seasoned issuer under Rule 405 of the Securities Act. As such, the Company has the ability to file shelf registration statements for unspecified amounts of various types of securities that become effective automatically upon filing, allowing for immediate, on-demand offerings.

During the first quarter of 2007, the Company recognized a pre-tax loss of $2.2 million from the redemption of the Junior Debentures underlying the Capital Securities of Delphi Funding L.L.C. On March 27, 2007, Delphi Funding L.L.C. redeemed the remaining $36.0 million liquidation amount of Capital Securities concurrently with the redemption by the Company of the underlying Junior Debentures held by Delphi Funding L.L.C. The redemption price was $1,046.55 per Capital Security plus accrued dividends. As a result, the $103.1 million principal amount of the Junior Debentures ceased to be outstanding and dividends on the Capital Securities ceased to accrue. The Company utilized borrowings under its Amended Credit Agreement and cash on hand to fund such redemption.

On May 23, 2007, the Company completed the issuance of $175.0 million of fixed-to-floating rate junior subordinated debentures (“2007 Junior Debentures”) in a public offering pursuant to an effective registration statement. See Note D to the Consolidated Financial Statements. The proceeds from this issuance were primarily used to repay the outstanding borrowings under the Amended Credit Agreement and for other general corporate purposes. The Company had $4.0 million outstanding under its Amended Credit Agreement as of September 30, 2007. On November 8, 2007, the Company and its bank lender group supplemented the Amended Credit Agreement, pursuant to its terms, to increase the maximum borrowings available under the facility to $350 million and to add two additional bank lenders.

The Company’s current liquidity needs, in addition to funding its operating expenses, include interest payments on the 2033 Senior Notes and 2007 Junior Debentures and distributions on the 2003 Capital Securities. The 2033 Senior Notes mature in their entirety in May 2033 and are not subject to any sinking fund requirements but are redeemable by the Company at par at any time on or after May 15, 2008. The junior subordinated deferrable interest debentures underlying the 2003 Capital Securities are redeemable, in whole or in part, beginning May 15, 2008. The 2007 Junior Debentures will become due on May 15, 2037, but only to the extent that the Company has received sufficient net proceeds from the sale of certain specified qualifying capital securities. Any remaining outstanding principal amount will be due on May 1, 2067. The Company may elect to redeem any or all of the 2007 Junior Debentures at any time. In the case of a redemption before May 15, 2017, the redemption price will be equal to the greater of 100% of the principal amount of the 2007 Junior Debentures being redeemed and the applicable make-whole amount, in each case plus any accrued and unpaid interest. In the case of a redemption on or after May 15, 2017, the redemption price will be equal to 100% of the principal amount of the debentures being redeemed plus any accrued and unpaid interest.

On November 7, 2007, the Company’s Board of Directors declared a cash dividend of $0.09 per share, which will be paid on the Company’s Class A Common Stock and Class B Common Stock on December 5, 2007.

The Company and its subsidiaries expect available sources of liquidity to exceed their current and long-term cash requirements.

Share Repurchase Program. During the third quarter of 2007, under the share repurchase program then in effect, the Company repurchased 45,500 shares of its Class A Common Stock for a total cost of $1.8 million with a volume weighted average price of $39.57 per share. On November 7, 2007, the Company’s Board of Directors authorized a new program under which up to 1,500,000 shares of the Company’s Class A Common Stock may be repurchased, which replaced the share repurchase program previously in effect. Share repurchases are effected by the Company in the open market or in privately negotiated transactions in compliance with the safe harbor provisions of Rule 10b-18 under the Securities Exchange Act of 1934. Executions of share repurchases by the Company are based on, among other things, management’s assessment of market conditions for its common stock and other potential uses of capital.

Investments. The Company’s overall investment strategy emphasizes safety and liquidity, while seeking the best available return, by focusing on, among other things, managing the Company’s interest-sensitive assets and liabilities and seeking to minimize the Company’s exposure to fluctuations in interest rates. The Company’s investment portfolio, which totaled $4.7 billion at September 30, 2007, consists primarily of investments in fixed maturity securities, mortgage loans, investments in limited partnerships, equity securities, trading account securities, investments in limited liability companies and short-term investments. During the first nine months of 2007, the market value of the Company’s investment portfolio, in relation to its amortized cost, decreased by $82.3 million from year-end 2006, before related changes in the cost of business acquired of $13.2 million and the income tax provision of $24.2 million. During the first nine months of 2007, the Company recognized pre-tax net investment losses of $0.9 million. The weighted average credit rating of the securities in the Company’s fixed maturity portfolio having ratings by Standard & Poor’s Corporation was “AA” at September 30, 2007. While ratings of this type address credit risk, they do not address other risks, such as prepayment and extension risks. See “Forward-Looking Statements and Cautionary Statements Regarding Certain Factors That May Affect Future Results,” Part I, Item 1A of the 2006 Form 10-K, “Risk Factors” for a discussion of various risks relating to the Company’s investment portfolio.

Reinsurance. The Company cedes portions of the risks relating to its group employee benefit products and variable life insurance products under indemnity reinsurance agreements with various unaffiliated reinsurers. The Company pays reinsurance premiums which are generally based upon specified percentages of the Company’s premiums on the business reinsured. These agreements expire at various intervals as to new risks, and replacement agreements are negotiated on terms believed appropriate in light of current market conditions. Effective October 1, 2007, the Company entered into a reinsurance agreement under which it cedes 75% (compared to 60% previously) of its excess workers’ compensation risks between $100.0 million and $150.0 million, per occurrence. Effective July 1, 2007, the Company entered into a reinsurance agreement under which it cedes 50% (compared to 100% previously) of its excess workers’ compensation risks between $5.0 million and $10.0 million, per occurrence. Effective January 1, 2007, the Company cedes through indemnity reinsurance risks in excess of $200,000 (compared to $150,000 previously) per individual and type of coverage for new and existing employer-paid group life insurance policies. Increases or reductions in the levels of the Company’s reinsurance coverages will increase or decrease, respectively, the reinsurance premiums paid by the Company under these arrangements and thus correspondingly decrease or increase the Company’s premium income. Reductions or increases in such reinsurance levels will also increase or decrease, respectively, the Company’s risk of loss with respect to the relevant policies.

Cash Flows. Operating activities increased cash by $280.1 million and $251.9 million in the first nine months of 2007 and 2006, respectively. Net investing activities used $265.8 million of cash during the first nine months of 2007 primarily for the purchase of securities. Financing activities used $16.8 million of cash principally for the repayment of outstanding borrowings under the Amended Credit Agreement and the redemption of the Junior Debentures held by Delphi Funding L.L.C., partially

offset by proceeds from the issuance of the 2007 Junior Debentures. In the first nine months of 2006, net investing activities used $337.8 million, primarily for the purchase of securities and financing activities provided $102.8 million, principally due to the issuance of funding agreements and an increase in borrowings under the Company’s revolving credit facility, partially offset by repurchases of the Company’s Class A Common Stock having a total cost of $16.6 million. During the third quarter of 2007, the Company received previously issued shares of Class B Common Stock having a fair value of $9.1 million in lieu of cash consideration for a stock option exercise. The value of the shares received in this transaction has been included in treasury stock.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

There have been no material changes in the Company’s exposure to market risk or its management of such risk since December 31, 2006.

Item 4. Controls and Procedures

As of the end of the period covered by this report, an evaluation was performed under the supervision and with the participation of the Company’s management, including the Company’s Chief Executive Officer (“CEO”) and Vice President and Treasurer (the individual who acts in the capacity of chief financial officer), of the effectiveness of the design and operation of the Company’s disclosure controls and procedures (as defined in the rules and regulations of the Securities and Exchange Commission). Based on that evaluation, the Company’s management, including the CEO and Vice President and Treasurer, concluded that the Company’s disclosure controls and procedures were effective. There were no changes in the Company’s internal control over financial reporting during the fiscal quarter to which this report relates that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

Forward-Looking Statements And Cautionary Statements Regarding Certain Factors That May Affect Future Results

In connection with, and because it desires to take advantage of, the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, the Company cautions readers regarding certain forward-looking statements in the above “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and elsewhere in this Form 10-Q and in any other statement made by, or on behalf of, the Company, whether in future filings with the Securities and Exchange Commission or otherwise. Forward-looking statements are statements not based on historical information and which relate to future operations, strategies, financial results, prospects, outlooks or other developments. Some forward-looking statements may be identified by the use of terms such as “expects,” “believes,” “anticipates,” “intends,” “judgment,” “outlook” or other similar expressions. Forward-looking statements are necessarily based upon estimates and assumptions that are inherently subject to significant business, economic, competitive and other uncertainties and contingencies, many of which are beyond the Company’s control and many of which, with respect to future business decisions, are subject to change. Examples of such uncertainties and contingencies include, among other important factors, those affecting the insurance industry generally, such as the economic and interest rate environment, federal and state legislative and regulatory developments, including but not limited to changes in financial services, employee benefit and tax laws and regulations, changes in accounting rules and interpretations thereof, market pricing and competitive trends relating to insurance products and services, acts of terrorism or war, and the availability and cost of reinsurance, and those relating specifically to the Company’s business, such as the level of its insurance premiums and fee income, the claims experience, persistency and other factors affecting the profitability of its insurance products, the performance of its investment portfolio and changes in the Company’s investment strategy, acquisitions of companies or blocks of business, and ratings by major rating organizations of the Company and its insurance subsidiaries. These uncertainties and contingencies can affect actual results and could cause actual results to differ materially from those expressed in any forward-looking statements made by, or on behalf of, the Company. Certain of these uncertainties and contingencies are described in more detail in Part I, Item 1A of the 2006 Form 10-K, “Risk Factors,” and Part II, Item 1A of this Quarterly Report, “Risk Factors.” The Company disclaims any obligation to update forward-looking information.

PART II. OTHER INFORMATION

Item 1A. Risk Factors

The following discussion, which supplements the significant factors that may affect our business and operations described in Part I, Item 1A of the 2006 Form 10-K, “Risk Factors,” updates and supercedes the discussion contained therein relating to this risk factor.

     The Company’s financial position and results of operations may be adversely impacted by changes in accounting rules and in the interpretations of such rules.

The Company’s financial position and results of operations are reported in accordance with GAAP, in the case of the Company, and in accordance with statutory accounting principles, in the case of the statutory financial statements of its insurance subsidiaries. Changes in the applicable GAAP or statutory accounting rules, or in the interpretations of such rules, may adversely affect the Company’s and such subsidiaries’ reported financial condition and results of operations.

As of January 1, 2007, the Company adopted the American Institute of Certified Public Accountants Statement of Position (“SOP”) 05-1, “Accounting by Insurance Enterprises for Deferred Acquisition Costs in Connection With Modifications or Exchanges of Insurance Contracts.” SOP 05-1 provides accounting guidance for deferred policy acquisition costs associated with internal replacements of insurance and investment contracts not addressed by previous guidance, including group insurance contracts. It defines an internal replacement as a modification in product benefits, features, rights, or coverages that occurs by the exchange of a contract for a new contract, or by amendment, endorsement or rider to a contract, or by the election of a feature or coverage within a contract. The after-tax reduction to the Company’s retained earnings resulting from the adoption of SOP 05-1 on January 1, 2007 was in the amount of $82.6 million, which represents the net reduction in the deferred policy acquisition cost from internal replacements included in cost of business acquired on the consolidated balance sheet. However, these matters involve a significant degree of interpretive judgment, and the Company’s interpretation is subject to future change due to the issuance of further accounting guidance regarding SOP 05-1 or its application by the accounting industry. It is therefore possible that this reduction will be adjusted, either upward or downward, in the event of such a change. An upward adjustment could materially adversely affect the Company’s consolidated financial position; in addition, changes required by future accounting guidance regarding SOP 05-1 or its implementation could materially adversely affect the Company’s results of operations.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

There were no unregistered sales of equity securities during the period covered by this report.

Issuer Purchases of Registered Equity Securities.

The following table shows the purchases of registered equity securities under the Company’s existing repurchase program during the three months ended September 30, 2007:

										Total Number
										of Shares				Maximum
										Purchased				Number of
										as Part				Shares that
		Total								of Publicly				May Yet Be
		Number of				Average				Announced				Purchased Under
		Shares				Price Paid				Plans				the Plans
		Purchased				per Share				or Programs(1)				or Programs(2)
July 1 – 31, 2007			—				—				—				—
August 1 – 31, 2007			45,500			$	39.57				45,500				888,176
September 1 – 30, 2007			—				—				—				—
Total			45,500			$	39.57				45,500				888,176

Item 6. Exhibits

10.1		Restricted Share Unit Amendment and Consolidation Agreement for Robert M. Smith, Jr.
11.1		Computation of Results per Share of Common Stock (incorporated by reference to Note H to the Consolidated Financial Statements included elsewhere herein)
31.1		Certification by the Chairman of the Board and Chief Executive Officer of Periodic Report Pursuant to Rule 13a-14(a) or 15d-14(a)
31.2		Certification by the Vice President and Treasurer of Periodic Report Pursuant to Rule 13a-14(a) or 15d-14(a)
32.1		Certification of Periodic Report Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		DELPHI FINANCIAL GROUP, INC. (Registrant)
		/s/		ROBERT ROSENKRANZ
		Robert Rosenkranz
		Chairman of the Board and Chief Executive Officer
		(Principal Executive Officer)
		/s/		THOMAS W. BURGHART
		Thomas W. Burghart
		Vice President and Treasurer
		(Principal Accounting and Financial Officer)

Date: November 9, 2007